Lexxema

Methylprednisolone aceponate, the active ingredient in Lexxema, is a corticosteroid presented as a topical formulation for skin use. It treats inflammatory skin conditions such as eczema, psoriasis and dermatitis in adults and children as prescribed by a healthcare professional, providing anti‑inflammatory and immunosuppressive effects to alleviate symptoms.

GNH USA supplies Lexxema as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable logistics for global distribution. The company adheres to Good Distribution Practice and offers temperature‑controlled shipping where required.

Lexxema, a topical glucocorticoid, is used to manage inflammatory skin disorders.

Eczema: Reduces inflammation, itching and redness associated with atopic dermatitis. Psoriasis: Decreases plaque formation and scaling in plaque psoriasis. Dermatitis: Controls inflammation and relieves symptoms in contact or seborrheic dermatitis. Other inflammatory skin disorders: Provides anti‑inflammatory relief in conditions such as lichen planus or discoid lupus erythematosus.

Topical application of Lexxema may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin irritation or burning sensation. - Dryness or peeling of the treated area. - Mild erythema. - Pruritus. - Folliculitis.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia formation. - Secondary infection (bacterial, fungal, viral). - Hypersensitivity reactions such as contact dermatitis. - Systemic adrenal suppression (rare).

Before using Lexxema, consider the following precautions.

- Indication: Use only for the skin conditions prescribed by a qualified healthcare professional. - Duration: Limit continuous use to the shortest period necessary to control symptoms. - Age: Caution in pediatric patients; follow pediatric dosing recommendations. - Application site: Avoid use on broken skin, open wounds, or mucous membranes. - Concomitant therapy: Do not combine with other potent topical steroids without medical advice. - Store at room temperature: Keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Lexxema may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: May increase risk of systemic glucocorticoid effects. - CYP3A4 inhibitors (e.g., ketoconazole): Can raise local steroid levels. - Antifungal agents applied to the same area: May enhance absorption and side effects. - Immunosuppressants: Potential additive immunosuppression. - Phototherapy: May increase skin irritation.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) used systemically: Monitor for systemic steroid side effects. - Antihistamines: No direct interaction but monitor skin response. - Herbal topical preparations: Assess for additive irritation. - Vaccines: Systemic immunosuppression may affect response if extensive absorption occurs. - Diabetes mellitus: Monitor blood glucose if systemic absorption is significant.